US Patent 8492102 Molecular diagnosis and classification of malignant melanoma
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+363 characters)
Article
Patent abstract
The present invention provides methods for diagnosing and providing a prognosis of melanoma using molecular markers that are overexpressed in melanoma cells. The invention provides kits for diagnosis and prognosis. Also provided are methods to identify compounds that are useful for the treatment or prevention of melanoma and melanoma progression.
Edits on 22 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Christopher Haqq0
Mohammed Kashani-Sabet0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08492102 Molecular diagnosis and classification of malignant melanoma US Patent 8492102 Molecular diagnosis and classification of malignant melanoma
Infobox
Patent Number
08492102
Patent Number
8492102
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08492102 Molecular diagnosis and classification of malignant melanoma
Infobox
Is a
Patent jurisdiction
Patent number
08492102
Date of patent
July 23, 2013
Patent application number
12920957
Date Filed
March 5, 2009
Patent primary examiner
Find more entities like US Patent 8492102 Molecular diagnosis and classification of malignant melanoma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
